Journal September 17, 2026 6 min read

How to Reconstitute MOTS-c: A Laboratory Research Guide

MOTS-c is a mitochondrial-derived peptide supplied as a lyophilized powder for laboratory research. This guide covers its identity, the mechanisms studied, and the practical steps for reconstitution in a research setting

peptides-pro Editorial

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a mitochondrial-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA. It is supplied as a lyophilized powder for laboratory research use only. The wild-type peptide sequence is Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg [4]. The peptide is amphipathic and cationic, consistent with the chemistry of known host defense peptides [1].

Research on MOTS-c centres on its role as a mitochondrial-derived regulator of metabolic and inflammatory pathways, with studies examining its interactions with the NLRP3 inflammasome, Nrf2 signalling, and cellular bioenergetics [2][4][12].

Research Studies

MOTS-c and host defense peptide function in bacterial models

MOTS-c was identified as a mitochondrial-encoded host defense peptide with direct antibacterial and immunomodulatory functions. The peptide was shown to target Escherichia coli and other bacterial strains in in vitro assays [1]. This work established that the mitochondrial genome can encode active immune factors, a function previously attributed exclusively to nuclear-encoded genes [1].

MOTS-c and NLRP3 inflammasome activity in a diabetic rat model

In a high-fat diet and streptozotocin-induced type 2 diabetes mellitus rat model, MOTS-c treatment significantly reduced fasting blood glucose and circulating C-reactive protein levels. The study reported selective modulation of plasma inflammatory markers and suppression of systemic and cardiac NLRP3 inflammasome activation [2]. These findings are animal-only and have not been confirmed in human clinical trials.

MOTS-c and thyroid autoimmunity in Hashimoto's thyroiditis

A cross-sectional study compared circulating MOTS-c levels in patients with Hashimoto's thyroiditis (n=90) and age- and sex-matched healthy controls. The study reported reduced circulating MOTS-c levels in the Hashimoto's thyroiditis group, suggesting an association with integrated autoimmune and metabolic dysregulation [3]. This is an observational finding and does not establish causation.

MOTS-c and radiation-induced lung injury in a LAT1-dependent model

Wild-type MOTS-c exhibits substantial antioxidant and anti-inflammatory properties but has poor membrane permeability due to its high polarity. An engineered analogue, R13A-MOTS-c, was created by substituting the polar arginine at position 13 with alanine, increasing the hydrophobicity index from -0.938 to -0.544. Functional uptake assays, including competition with canonical LAT1 substrates (leucine, BCH) and LAT1 knockdown experiments, confirmed that R13A-MOTS-c enters cells via LAT1-mediated delivery. In this model, R13A-MOTS-c attenuated radiation-induced lung injury via Nrf2 activation and mitochondrial protection [4]. This work was conducted in preclinical models.

MOTS-c and atrial fibrillation in human tissue and mouse models

A study investigated humanin and MOTS-c expression in human atrial tissues using public GEO data, immunohistochemistry, and immunofluorescence, and evaluated their therapeutic potential in an angiotensin II-induced mouse model and primary cardiac cells. The study reported that humanin and MOTS-c attenuated atrial fibrillation by suppressing fibrosis and mitochondrial dysfunction [5]. The human tissue analysis was observational, while the mechanistic findings were derived from animal and cell models.

MOTS-c and myocardial ischemia-reperfusion injury in acute myocardial infarction

A cross-sectional study enrolled 72 acute myocardial infarction patients undergoing percutaneous coronary intervention, divided into myocardial ischemia-reperfusion injury (MIRI, n=34) and non-MIRI (n=38) groups. The study examined MOTS-c levels in peripheral serum and intracoronary blood and investigated the association between serum MOTS-c levels and MIRI [6]. This is an observational study and does not establish a causal relationship.

MOTS-c and polycystic ovary syndrome in adolescents

A study investigated differences in MOTS-c levels between adolescents diagnosed with polycystic ovary syndrome (PCOS) and those without, as well as associations with metabolic parameters. The study also evaluated the association between the MOTS-c gene polymorphism m.1382A>C and serum MOTS-c levels in this population [7]. This is an observational study.

MOTS-c and renal transplantation under different anesthetic techniques

A prospective controlled study aims to compare the effects of sevoflurane general anesthesia and combined spinal-epidural anesthesia on ferroptosis, humanin, and MOTS-c levels in renal transplantation. The study is designed to investigate whether different anesthetic techniques affect these biomarkers in kidney transplant recipients [8]. This is an ongoing clinical trial; results are not yet available.

MOTS-c and mesenchymal stromal cell function in obesity

MOTS-c is known to regulate cellular metabolism, but its effects on mesenchymal stromal cells (MSCs) under obese conditions were examined. The study reported that MOTS-c activates metabolic signalling but blunts reparative function in human mesenchymal stromal cells [10]. This is an in vitro study using human cells.

MOTS-c and cardiac ischemia-reperfusion injury in preclinical models

MOTS-c has been implicated in preserving mitochondrial subpopulation bioenergetics and genome integrity to attenuate cardiac ischemia-reperfusion injury. The study examined mitochondrial dysfunction, impaired bioenergetics, oxidative stress, and disruption of mitochondrial homeostasis in preclinical models [12]. This is a reference-only item and is not the focus of this guide.

MOTS-c and sepsis-induced cardiomyopathy

Sepsis-induced cardiomyopathy is characterized by inflammatory dysregulation, mitochondrial dysfunction, metabolic disturbance, and changes in the myocardial microenvironment. MOTS-c has been studied in this context for its mechanisms and translational potential [9]. This is a reference-only item and is not the focus of this guide.

MOTS-c and inflammatory lung diseases

MOTS-c is a mitochondrial-derived microprotein encoded within the 12S rRNA gene that exerts intracrine, paracrine, and endocrine effects across multiple tissues. Growing evidence indicates that MOTS-c modulates oxidative stress and inflammatory pathways, and it has been proposed as a potential treatment for inflammatory lung diseases [11]. This is a reference-only item and is not the focus of this guide.

Reconstitution Procedure

MOTS-c is supplied as a lyophilized powder. For laboratory research use, reconstitution is typically performed with bacteriostatic water or sterile saline. The choice of solvent depends on the intended application and the solubility of the peptide. The wild-type peptide sequence is Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg [4].

To reconstitute, add the solvent slowly to the vial, aiming the stream at the wall rather than directly at the powder. Gently swirl or roll the vial between your hands; do not shake vigorously, as this can cause foaming and denaturation. Allow the powder to dissolve completely. If necessary, let the vial stand at room temperature for a few minutes. The resulting solution should be clear and colourless. If particulates are visible, do not use the preparation.

For storage, keep the lyophilized powder at -20°C, protected from light and moisture. Once reconstituted, store the solution at 2–8°C for short-term use, or aliquot and freeze at -20°C or -80°C for longer-term storage. Avoid repeated freeze-thaw cycles.

Handling and Safety

This product is sold for laboratory research use only. It is not for human or veterinary use. Handle in a laboratory setting with appropriate personal protective equipment, including gloves, lab coat, and eye protection. Avoid inhalation, ingestion, and contact with skin and eyes. Dispose of waste according to institutional guidelines.

If you are reading this for personal health reasons

This material is sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.